Public Sector Pension Investment Board increased its holdings in shares of ICL Group Ltd (NYSE:ICL – Free Report) by 5.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 322,534 shares of the basic materials company’s stock after buying an additional 15,405 shares during the period. Public Sector Pension Investment Board’s holdings in ICL Group were worth $1,396,000 at the end of the most recent quarter.
Other large investors have also bought and sold shares of the company. Massmutual Trust Co. FSB ADV raised its position in shares of ICL Group by 103.8% during the 1st quarter. Massmutual Trust Co. FSB ADV now owns 7,093 shares of the basic materials company’s stock valued at $38,000 after acquiring an additional 3,612 shares during the last quarter. Kathmere Capital Management LLC bought a new stake in ICL Group in the first quarter valued at about $54,000. Callan Capital LLC acquired a new position in ICL Group in the first quarter valued at about $60,000. Greenleaf Trust bought a new position in ICL Group during the first quarter worth about $63,000. Finally, Choreo LLC acquired a new position in shares of ICL Group during the 2nd quarter worth about $67,000. 13.38% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
ICL has been the topic of a number of analyst reports. StockNews.com downgraded shares of ICL Group from a “strong-buy” rating to a “buy” rating in a research report on Monday. Barclays cut their target price on shares of ICL Group from $4.50 to $4.00 and set an “underweight” rating on the stock in a report on Friday, August 16th.
ICL Group Stock Up 0.4 %
NYSE:ICL opened at $4.27 on Wednesday. The stock has a market cap of $5.60 billion, a price-to-earnings ratio of 11.53, a PEG ratio of 5.06 and a beta of 1.23. The company has a current ratio of 1.62, a quick ratio of 0.94 and a debt-to-equity ratio of 0.31. The stock has a 50-day moving average price of $4.19 and a two-hundred day moving average price of $4.53. ICL Group Ltd has a 1 year low of $3.79 and a 1 year high of $5.72.
ICL Group (NYSE:ICL – Get Free Report) last posted its earnings results on Wednesday, August 14th. The basic materials company reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.09 by $0.01. ICL Group had a return on equity of 8.41% and a net margin of 6.08%. The business had revenue of $1.75 billion during the quarter, compared to analysts’ expectations of $1.73 billion. During the same period in the prior year, the business earned $0.13 EPS. As a group, equities analysts expect that ICL Group Ltd will post 0.36 earnings per share for the current year.
ICL Group Cuts Dividend
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 18th. Investors of record on Wednesday, September 4th were issued a dividend of $0.037 per share. The ex-dividend date was Wednesday, September 4th. This represents a $0.15 dividend on an annualized basis and a dividend yield of 3.47%. ICL Group’s payout ratio is presently 37.84%.
ICL Group Company Profile
ICL Group Ltd, together with its subsidiaries, operates as a specialty minerals and chemicals company worldwide. It operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Growing Solutions. The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; produces various grades of potash, salt, magnesium chloride, and magnesia products; and produces and markets phosphorous-based flame retardants and other phosphorus-based products.
Recommended Stories
- Five stocks we like better than ICL Group
- The 3 Best Blue-Chip Stocks to Buy Now
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Want to see what other hedge funds are holding ICL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICL Group Ltd (NYSE:ICL – Free Report).
Receive News & Ratings for ICL Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICL Group and related companies with MarketBeat.com's FREE daily email newsletter.